Often, analysts’ stock picks are best ignored

There’s an old saying that the stock market will do whatever it takes to make most investors look foolish. I’ve conducted a study that shows it often makes fools of analysts, as well.

In 1998, I started tracking the four stocks Wall Street analysts love the best at the beginning of each calendar year, and the four stocks they most hate. There are no data for 2008, when I was temporarily retired as a columnist.

Last year, the darlings achieved a 10.4 percent return, trailing the Standard & Poor’s 500 index’s by 16 percent. Both figures include reinvested dividends. It was the 11th year out of 14 that analysts’ favorite stocks have failed to beat the S&P 500.


The analysts had one consolation last year: Their favorites beat the stocks they most hated at the beginning of the year. The latter were up 3.1 percent.

Get Talking Points in your inbox:
An afternoon recap of the day’s most important business news, delivered weekdays.
Thank you for signing up! Sign up for more newsletters here

A 53 percent gain in Polaris Industries Inc. and a 39 percent advance by Tesoro Logistics LP helped the analysts. They were hurt by a 9 percent decline in Micros Systems Inc. and a 42 percent plunge by LogMeIn Inc.

Three of the four stocks they hated at the start of 2012 — Mercury General Corp., Ferrellgas Partners LP, and Frontline Ltd. — were losers for the year. But the one they despised most, Sears Holdings Corp., returned 45 percent.

The long-term results are worse.

The 14-year average for analysts’ favorite stocks is a gain of 0.15 percent. The average for the despised stocks is a gain of 6.12 percent. For comparison, the average for the S&P 500 for those 14 years was 10.2 percent.


In 14 outings, the analysts’ hates have beaten the ones they love seven times. The adored stocks have won six times, and one year (1998) was a tie.

The moral is that the best pickings are usually found in the middle, in stocks about which analysts disagree.

How can analysts — well paid, well educated, well informed, and well equipped — do so badly? It’s simple. Like most humans, they tend to extrapolate recent success or failure into the future. But the world is unpredictable and cyclical. Let’s look at the stocks for which the analytical corps currently shows the greatest enthusiasm.

Liberty Global Inc. gets the blue ribbon, with 12 buy recommendations and no dissenting votes. It beats me why. Liberty is the non-US portion of John Malone’s cable-and-media empire. It has more than 200 subsidiaries, many of them cable companies, in Europe, Asia, and Latin America. It has debt of about 800 percent of equity, and posted a loss in five of the past seven years. Group provides website services for small businesses. It rates 11 buys, with no holds or sells. I don’t like this one, either. It has posted losses in four of the past seven years.


MarkWest Energy Partners LP also has 11 buys. It boasts a nice dividend yield, but I consider the stock pricey.

Nu Skin Enterprises Inc. distributes high-end cosmetics and nutritional supplements. Its five-year earnings growth rate is about 30 percent; the 10 analysts who cover it anticipate more of the same. They are too optimistic.

And now, the less-liked stocks.

Ferrellgas LP, a propane distributor, is the most hated, with six sell ratings and one hold. After two years of losses, its net worth has gone negative.

Getty Realty Corp., which rents sites to gas stations, is rated sell by three of four analysts who cover it. I recommended it in April 2011, and it has fallen about 21 percent since then. Its relationship with Getty Petroleum Marketing has soured, and it has been scrambling to find other tenants.

Osiris Therapeutics Inc. is a small company working on bone marrow regeneration after chemotherapy. It garners one hold and three sells.

Sears Holdings Corp. is on analysts’ blacklists for the third year in a row, this time with four sells out of six ratings. Hedge fund manager Eddie Lampert is trying to turn the big retailer around, but it’s a struggle.

I don’t own any of the stocks above. If you made me choose, I’d own the despised stocks this year, not the adored ones.

John Dorfman is chairman of Thunderstorm Capital in Boston. His firm or clients may own or trade securities discussed in this column.